Literature DB >> 18644850

Liver tumors in children.

Jason B Litten1, Gail E Tomlinson.   

Abstract

Malignant liver tumors account for slightly >1% of all pediatric malignancies, with roughly 150 new cases of liver tumors diagnosed in the U.S. annually. The embryonal tumor, hepatoblastoma, accounts for two thirds of malignant liver tumors in children. Other liver malignancies in children include hepatocellular carcinoma, sarcomas, germ cell tumors, and rhabdoid tumors. Benign tumors of the liver in children include vascular tumors, hamartomas, and adenomas. There is an apparent increase in the incidence of hepatoblastoma with perinatal exposures and decreased premature infant mortality as postulated causes for this increased risk. The known causes and associations of liver tumors in children as well as the approaches to diagnosis and treatment of children are discussed in this review article.

Entities:  

Mesh:

Year:  2008        PMID: 18644850     DOI: 10.1634/theoncologist.2008-0011

Source DB:  PubMed          Journal:  Oncologist        ISSN: 1083-7159


  57 in total

1.  Adult hepatoblastoma successfully treated with multimodal treatment.

Authors:  Shinji Nakamura; Masayuki Sho; Hiromichi Kanehiro; Toshihiro Tanaka; Kimihiko Kichikawa; Yoshiyuki Nakajima
Journal:  Langenbecks Arch Surg       Date:  2010-04-11       Impact factor: 3.445

Review 2.  Magnetic resonance imaging of primary pediatric liver tumors.

Authors:  Brian S Pugmire; Alexander J Towbin
Journal:  Pediatr Radiol       Date:  2016-05-26

Review 3.  Natural compounds for pediatric cancer treatment.

Authors:  Veronica Ferrucci; Iolanda Boffa; Gina De Masi; Massimo Zollo
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2015-12-09       Impact factor: 3.000

4.  Hepatoblastomas in Oman: Unveiling success.

Authors:  Fatma Rabah; Nagwa El-Banna; Dipali Bhuyan; Ibrahim Al-Ghaithi; Mohamed Al-Hinai; Amal Al-Sabahi; Nawal Al-Mashaikhi; Ismail Beshlawi
Journal:  Sultan Qaboos Univ Med J       Date:  2015-01-21

5.  Current therapeutic strategies for childhood hepatic malignant tumors.

Authors:  Eiso Hiyama
Journal:  Int J Clin Oncol       Date:  2013-09-21       Impact factor: 3.402

6.  Solamargine inhibits the migration and invasion of HepG2 cells by blocking epithelial-to-mesenchymal transition.

Authors:  Xiaodong Xie; Haitao Zhu; Jia Zhang; Meiqin Wang; Li Zhu; Zhen Guo; Wenrong Shen; Dongqing Wang
Journal:  Oncol Lett       Date:  2017-05-10       Impact factor: 2.967

7.  Defining an optimal time window to screen for hepatoblastoma in children with Beckwith-Wiedemann syndrome.

Authors:  Alessandro Mussa; Kelly A Duffy; Diana Carli; Giovanni Battista Ferrero; Jennifer M Kalish
Journal:  Pediatr Blood Cancer       Date:  2018-09-30       Impact factor: 3.167

8.  Metastatic hepatocellular carcinoma in a juvenile rhesus macaque (Macaca mulatta).

Authors:  Steven T Laing; Marie J Lemoy; Rebecca L Sammak; Ross P Tarara
Journal:  Comp Med       Date:  2013-10       Impact factor: 0.982

9.  Genome-wide analysis of DNA methylation in hepatoblastoma tissues.

Authors:  Ximao Cui; Baihui Liu; Shan Zheng; Kuiran Dong; Rui Dong
Journal:  Oncol Lett       Date:  2016-06-28       Impact factor: 2.967

Review 10.  Syndrome-Associated Tumors by Organ System.

Authors:  Raul S Gonzalez; Nicole D Riddle
Journal:  J Pediatr Genet       Date:  2016-03-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.